Keyphrases
Long-acting β2-agonist
100%
Asthma
100%
Safety Study
100%
Enantioselectivity
100%
Salbutamol
100%
Bronchial Hyperresponsiveness
80%
S-enantiomer
60%
Salmeterol
40%
Formoterol
40%
Bronchodilatation
40%
Inhaled Corticosteroids
40%
Racemic Mixture
20%
Chiral Molecules
20%
Enantiospecificity
20%
Asthma Exacerbation
20%
Steroid-sparing
20%
Long-term Treatment
20%
Asthma Control
20%
Deleterious Effects
20%
Bronchodilator Effect
20%
Pharmacodynamics
20%
Short-acting
20%
Racemic
20%
Emergency Department
20%
Biological Plausibility
20%
Pharmacology, Toxicology and Pharmaceutical Science
Salbutamol
100%
Asthma
100%
Formoterol
40%
Salmeterol
40%
Pharmacokinetic
20%
Bronchodilating Agent
20%
Pharmacodynamics
20%